Cannabis, collaterals, and coronary occlusion

Kalpa De Silva1, Divaka Perera1

  • 1Cardiovascular Division, Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK.

Insights

Cannabis use may protect against severe heart attack consequences. This case study suggests collateral circulation and potential cannabinoid preconditioning mitigate ischemia severity in acute left main coronary artery occlusion.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Cannabis contains endogenous cannabinoids which may induce myocardial preconditioning.
  • Cannabinoid-induced preconditioning might offer cardioprotection during ischemic events.

Observation:

  • A 51-year-old male with regular cannabis use presented with chest pain and diaphoresis.
  • ECG revealed ST depression and ST elevation in lead aVR, indicating myocardial ischemia.
  • Coronary angiography showed acute thrombotic occlusion of the left main coronary artery (LMCA).

Findings:

  • The patient was hemodynamically stable despite LMCA occlusion.
  • Successful revascularization of the LMCA was achieved with a bare-metal stent.
  • The dominant right coronary artery (RCA) provided significant collateral circulation to the left anterior descending artery (LAD).

Implications:

  • Coronary collateralization and potential cannabinoid preconditioning may ameliorate the severity of ischemia and its consequences.
  • This case highlights a potential protective effect of cannabis use in acute coronary syndromes.
  • Further research is warranted to explore the role of cannabinoids in myocardial protection.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...